硕世生物
(688399)
| 流通市值：40.62亿 | | | 总市值：40.62亿 |
| 流通股本：5667.01万 | | | 总股本：5667.01万 |
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 每股收益(元) | 0.46 | 0.50 | 0.68 | -6.38 | -3.00 | -1.17 | -0.33 | 31.18 |
| 每股净资产(元) | 56.07 | 58.59 | 58.77 | 58.09 | 61.46 | 63.30 | 64.12 | 64.45 |
| 每股资本公积金(元) | 13.79 | 13.76 | 13.76 | 13.76 | 13.76 | 13.76 | 13.75 | 13.75 |
| 每股未分配利润(元) | 43.29 | 43.33 | 43.51 | 42.83 | 46.20 | 48.04 | 48.87 | 49.20 |
| 每股经营性现金流(元) | 1.65 | 1.27 | 0.90 | -1.93 | -4.73 | -6.64 | -3.86 | 33.52 |
| 净资产收益率(%) | 0.80 | 0.86 | 1.17 | -10.41 | -4.77 | -1.82 | -0.52 | 58.80 |
| 营业总收入(元) | 2.68亿 | 1.77亿 | 9111.94万 | 4.03亿 | 2.76亿 | 1.87亿 | 9405.37万 | 55.35亿 |
营业总收入同比增长(%) | -3.02 | -4.91 | -3.12 | -92.72 | -93.56 | -94.29 | -93.82 | 94.95 | | 归属净利润(元) | 2711.47万 | 2924.05万 | 4006.80万 | -37381.14万 | -17601.43万 | -6829.47万 | -1942.40万 | 18.28亿 |
| 归属净利润同比增长(%) | 115.40 | 142.82 | 306.28 | -120.45 | -110.84 | -105.54 | -103.08 | 53.19 |
| 扣非净利润(元) | -1646.51万 | -212.52万 | 1487.41万 | -42920.11万 | -20529.74万 | -9168.52万 | -3429.25万 | 17.66亿 |
|
| 扣非净利润同比增长(%) | 91.98 | 97.68 | 143.37 | -124.31 | -112.79 | -107.50 | -105.49 | 54.93 |
| 毛利率(%) | 65.66 | 68.13 | 70.93 | 63.91 | 60.12 | 64.74 | 65.20 | 60.62 |
| 净利率(%) | 10.11 | 16.48 | 43.97 | -92.72 | -63.67 | -36.60 | -20.65 | 33.03 |
| 资产负债率(%) | 14.78 | 14.23 | 14.58 | 12.83 | 15.94 | 14.69 | 20.29 | 22.75 |
| 存货周转率(次) | 0.95 | 0.59 | 0.27 | 0.88 | 0.53 | 0.28 | 0.14 | 8.96 |